213 related articles for article (PubMed ID: 17300726)
1. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.
Lin PY; Fosmire SP; Park SH; Park JY; Baksh S; Modiano JF; Weiss RH
Mol Cancer; 2007 Feb; 6():16. PubMed ID: 17300726
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
3. Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells.
Park JK; Jung HY; Park SH; Kang SY; Yi MR; Um HD; Hong SH
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1552-60. PubMed ID: 18374229
[TBL] [Abstract][Full Text] [Related]
4. S100A11 is involved in the regulation of the stability of cell cycle regulator p21(CIP1/WAF1) in human keratinocyte HaCaT cells.
Foertsch F; Teichmann N; Kob R; Hentschel J; Laubscher U; Melle C
FEBS J; 2013 Aug; 280(16):3840-53. PubMed ID: 23745637
[TBL] [Abstract][Full Text] [Related]
5. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.
Hlobilkova A; Knillova J; Svachova M; Skypalova P; Krystof V; Kolar Z
Anticancer Res; 2006; 26(2A):1015-22. PubMed ID: 16619501
[TBL] [Abstract][Full Text] [Related]
6. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer.
Zheng L; Zhang Y; Liu Y; Zhou M; Lu Y; Yuan L; Zhang C; Hong M; Wang S; Li X
J Transl Med; 2015 Aug; 13():252. PubMed ID: 26238857
[TBL] [Abstract][Full Text] [Related]
7. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27.
Hsu YH; Chang CC; Yang NJ; Lee YH; Juan SH
J Cell Physiol; 2014 Oct; 229(10):1455-65. PubMed ID: 24535918
[TBL] [Abstract][Full Text] [Related]
8. Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma.
Wang H; Zhang P; Lin C; Yu Q; Wu J; Wang L; Cui Y; Wang K; Gao Z; Li H
PLoS One; 2015; 10(2):e114250. PubMed ID: 25714556
[TBL] [Abstract][Full Text] [Related]
9. PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation.
Lee JJ; Kim BC; Park MJ; Lee YS; Kim YN; Lee BL; Lee JS
Cell Death Differ; 2011 Apr; 18(4):666-77. PubMed ID: 21072054
[TBL] [Abstract][Full Text] [Related]
10. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis.
Chung JH; Eng C
Cancer Res; 2005 Sep; 65(18):8096-100. PubMed ID: 16166282
[TBL] [Abstract][Full Text] [Related]
11. TSPYL5 is involved in cell growth and the resistance to radiation in A549 cells via the regulation of p21(WAF1/Cip1) and PTEN/AKT pathway.
Kim EJ; Lee SY; Kim TR; Choi SI; Cho EW; Kim KC; Kim IG
Biochem Biophys Res Commun; 2010 Feb; 392(3):448-53. PubMed ID: 20079711
[TBL] [Abstract][Full Text] [Related]
12. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
[TBL] [Abstract][Full Text] [Related]
13. Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor.
Hara S; Oya M; Mizuno R; Horiguchi A; Marumo K; Murai M
Ann Oncol; 2005 Jun; 16(6):928-33. PubMed ID: 15851405
[TBL] [Abstract][Full Text] [Related]
14. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
[TBL] [Abstract][Full Text] [Related]
15. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.
Yang SM; Huang C; Li XF; Yu MZ; He Y; Li J
Toxicology; 2013 Apr; 306():162-8. PubMed ID: 23466500
[TBL] [Abstract][Full Text] [Related]
16. Matrine activates PTEN to induce growth inhibition and apoptosis in V600EBRAF harboring melanoma cells.
Jin H; Sun Y; Wang S; Cheng X
Int J Mol Sci; 2013 Jul; 14(8):16040-57. PubMed ID: 23912239
[TBL] [Abstract][Full Text] [Related]
17. Targeting phosphoinositide 3-kinase: moving towards therapy.
Marone R; Cmiljanovic V; Giese B; Wymann MP
Biochim Biophys Acta; 2008 Jan; 1784(1):159-85. PubMed ID: 17997386
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the inhibition of leukemia cell growth and induction of apoptosis through the activation of ATR and PTEN by the topoisomerase inhibitor 3EZ, 20Ac-ingenol.
Miyata S; Fukuda Y; Tojima H; Matsuzaki K; Kitanaka S; Sawada H
Leuk Res; 2015 Sep; 39(9):927-32. PubMed ID: 26194899
[TBL] [Abstract][Full Text] [Related]
19. Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma.
He L; Fan C; Gillis A; Feng X; Sanatani M; Hotte S; Kapoor A; Tang D
Biochim Biophys Acta; 2007 Oct; 1772(10):1134-42. PubMed ID: 17681738
[TBL] [Abstract][Full Text] [Related]
20. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
